Neuphoria Therapeutics Inc. · NASDAQ:NEUP
AdvisorShares Trust reported a 5.78% stake in Neuphoria Therapeutics Inc. (Schedule 13G)
Event Sep 30, 2026 · Filed Oct 5, 2026
AdvisorShares Trust reported a 5.78% stake in Neuphoria Therapeutics Inc., 312,895 shares, as a passive investor on Sep 30, 2026. Filed Oct 5, 2026 (Schedule 13G).
- Stake
- 5.78%
- Shares
- 312,895
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| AdvisorShares Trust | 5.78% | 312,895 |
Source
Related
- Neuphoria Therapeutics Inc.
- AdvisorShares Trust
- Neuphoria Therapeutics Inc. shareholders
- Schedule 13G/A · Coastlands Capital LP · Jul 28, 2026
- Schedule 13G/A · Baselake Partners, LP · Feb 6, 2026
- Schedule 13D/A · Lynx1 Capital Management LP · Dec 29, 2025
- Schedule 13D/A · Lynx1 Capital Management LP · Dec 2, 2025
- Schedule 13D/A · Lynx1 Capital Management LP · Nov 28, 2025